Sort
16,300 grants matching “fatty liver disease”
Postprandial activation of hyaluronan-MARCO axis contributes to systemic chronic inflammation
$416,464Yi Zhu · Baylor College Of Medicine · R01 · FY2024 · DK
Gaining Metabolic Insight in Older Men undergoing Androgen Deprivation Therapy for Prostate Cancer
$416,443Shehzad Basaria · Brigham And Women'S Hospital · R01 · FY2020 · CA
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH
$416,408Michael Ohliger · University Of California, San Francisco · R01 · FY2018 · DK
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
$416,402Michael Karin · University Of California, San Diego · R01 · FY2020 · DK
Leveraging arginase biology against metabolic disease
$416,258Brian Jesse Debosch · Washington University · R01 · FY2024 · DK
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH
$416,246Michael Ohliger · University Of California, San Francisco · R01 · FY2019 · DK
Identifying genes required for digestive physiology and lipid metabolism
$416,034Steven A Farber · Carnegie Institution Of Washington, D.C. · R01 · FY2017 · DK
PPARgamma-regulated mechanisms in hepatocytes that promote NAFLD
$416,017Jose Cordoba-Chacon · University Of Illinois At Chicago · R01 · FY2023 · DK
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
$415,961Michael Karin · University Of California, San Diego · R01 · FY2019 · DK
Fatty Liver Disease and Hepatic Energy Homostatis in SH*
$415,935Johns Hopkins University · R01 · FY2003 · DK
Ceramide and acute phase proteins elevation during aging
$415,845Mariana Nikolova-Karakashian · University Of Kentucky · R01 · FY2022 · AG
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH
$415,817Michael Ohliger · University Of California, San Francisco · R01 · FY2020 · DK
CSN8 regulation of S1P-enriched extracellular vesicles to modulate NAFLD by gut-liver axis
$415,800Zhong-Bin Deng · University Of Louisville · R01 · FY2018 · DK
PROJECT 2
$415,678Daniel A Beard · Medical College Of Wisconsin · P50 · FY2012 · GM
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH
$415,502Michael Ohliger · University Of California, San Francisco · R01 · FY2021 · DK
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH
$415,502Michael Ohliger · University Of California, San Francisco · R01 · FY2022 · DK
Environmental arsenic and diabetes mellitus
$415,484Miroslav Styblo · Univ Of North Carolina Chapel Hill · R01 · FY2009 · ES
Role of SAMe in the Progression of Nonalcoholic Fatty Liver Disease
$415,346Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · R01 · FY2021 · DK
NAD+ and metabolic flexibility
$415,320Samuel Klein · Washington University · R01 · FY2024 · DK
Prospective Evaluation of Acute Kidney Injury (PEAK) Cohort
$415,302Alan S Go · Kaiser Foundation Research Institute · U01 · FY2011 · DK
Prospective Evaluation of Acute Kidney Injury (PEAK) Cohort
$415,300Alan S Go · Kaiser Foundation Research Institute · U01 · FY2009 · DK
Jagged-Notch signaling in NASH/fibrosis
$415,175Utpal Pajvani · Columbia University Health Sciences · R01 · FY2019 · DK
Neutrophil elastase in obesity-related fatty liver diseases
$415,152Zhen Yue Jiang · Boston University Medical Campus · R01 · FY2022 · DK
Environmental Exposure and Cardiometabolic Disease
$415,147Sanjay Srivastava · University Of Louisville · P42 · FY2019 · ES
Docosahexaenoic Acid Loaded Low-density Lipoproteins: A Novel Biologic Intervention for Hepatocellular Carcinoma.
$415,130Ian Ronald Corbin · Ut Southwestern Medical Center · R01 · FY2024 · CA